journal article·2012-10-23

Synthesis andIn VivoPharmacokinetic Evaluation of Degradable Shell Cross-Linked Polymer Nanoparticles with Poly(carboxybetaine)versusPoly(ethylene glycol) Surface-Grafted Coatings

Ang Li, Hannah P. Luehmann, Guorong Sun, Sandani Samarajeewa, Jiong Zou, Shiyi Zhang, Fuwu Zhang, Michael J. Welch, Yongjian Liu, Karen L. Wooley

ACS Nano· Volume 6· Issue 10
Publisher page

Abstract

Nanoparticles with tunable pharmacokinetics are desirable for various biomedical applications. Poly(ethylene glycol) (PEG) is well-known to create "stealth" effects to stabilize and extend the blood circulation of nanoparticles. In this work, poly(carboxybetaine) (PCB), a new nonfouling polymer material, was incorporated as surface-grafted coatings, conjugated onto degradable shell cross-linked knedel-like nanoparticles (dSCKs) composed of poly(acrylic acid)-based shells and poly(lactic acid) cores, to compare the in vivo pharmacokinetics to their PEG-functionalized analogues. A series of five dSCKs was prepared from amphiphilic block copolymers, having different numbers and lengths of either PEG or PCB grafts, by supramolecular assembly in water followed by shell cross-linking, and then studied by a lactate assay to confirm their core hydrolytic degradabilities. Each dSCK was also conjugated with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid macrocyclic chelators and tyramine moieties to provide for (64)Cu and/or radiohalogen labeling. The high specific activity of (64)Cu radiolabeling ensured nanogram administration of dSCKs for in vivo evaluation of their pharmacokinetics. Biodistribution studies demonstrated comparable in vivo pharmacokinetic profiles of PCB-grafted dSCKs to their PEG-conjugated counterparts. These results indicated that PCB-functionalized dSCKs have great potential as a theranostic platform for translational research.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Polymer Surface Interaction Studies · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departments of Chemistry and Chemical Engineering, Texas A&M University, College Station, Texas 77842, United States

Department of Radiology, Washington University, St. Louis, Missouri 63110, United States

References (58)

Show source-provided references
1. Nyström A. M. · Acc. Chem. Res. · 2011 · 44 · 96910.1021/ar200097k ↗
2. Brigger I. · Adv. Drug Delivery Rev. · 2002 · 54 · 63110.1016/S0169-409X(02)00044-3 ↗
3. Torchilin V. P. · Adv. Drug Delivery Rev. · 2006 · 58 · 153210.1016/j.addr.2006.09.009 ↗
4. Wang A. Z. · Annu. Rev. Med. · 2012 · 63 · 18510.1146/annurev-med-040210-162544 ↗
5. Liu Y. · Bioconjugate Chem. · 2012 · 23 · 67110.1021/bc200264c ↗
6. Elsabahy M. · Chem. Soc. Rev. · 2012 · 41 · 254510.1039/c2cs15327k ↗
7. Schober O. · Eur. J. Nucl. Med. Mol. Imaging · 2009 · 36 · 30210.1007/s00259-008-1042-4 ↗
8. Gref R. · Science · 1994 · 263 · 160010.1126/science.8128245 ↗
9. Khlebtsov N. · Chem. Soc. Rev. · 2011 · 40 · 164710.1039/C0CS00018C ↗
10. Owens D. E. · Int. J. Pharm. · 2006 · 307 · 9310.1016/j.ijpharm.2005.10.010 ↗
11. Li S. D. · Mol. Pharmaceutics · 2008 · 5 · 49610.1021/mp800049w ↗
12. Venkataraman S. · Adv. Drug Delivery Rev. · 2011 · 63 · 122810.1016/j.addr.2011.06.016 ↗
13. Elsabahy M. · J. Polym. Sci., Part A: Polym. Chem. · 2012 · 50 · 186910.1002/pola.25955 ↗
14. Hume D. A. · Curr. Opin. Immunol. · 2006 · 18 · 4910.1016/j.coi.2005.11.008 ↗
15. Vonarbourg A. · Biomaterials · 2006 · 27 · 435610.1016/j.biomaterials.2006.03.039 ↗
16. Moghimi S. M. · Pharmacol. Rev. · 2001 · 53 · 28310.1016/S0031-6997(24)01494-7 ↗
17. Peracchia M. T. · Pharm. Res. · 1998 · 15 · 55010.1023/A:1011973625803 ↗
18. Mintezer M. A. · Chem. Rev. · 2009 · 109 · 25910.1021/cr800409e ↗
19. Ganson N. J. · Arthritis Res. Ther. · 2006 · 8 · R1210.1186/ar1861 ↗
20. Armstrong J. K. · Cancer · 2007 · 110 · 10310.1002/cncr.22739 ↗
21. Ostuni E. · Langmuir · 2001 · 17 · 560510.1021/la010384m ↗
22. Shen M. · J. Biomater. Sci., Polym. Ed. · 2002 · 13 · 36710.1163/156856202320253910 ↗
23. Li L. · J. Biomater. Sci., Polym. Ed. · 2007 · 18 · 141510.1163/156856207782246795 ↗
24. Gaberc-Porekar V. · Curr. Opin. Drug Discovery Dev. · 2008 · 11 · 242
25. Veronese F. M. · Biodrugs · 2008 · 22 · 31510.2165/00063030-200822050-00004 ↗
26. Chapman A. P. · Adv. Drug Delivery Rev. · 2002 · 54 · 53110.1016/S0169-409X(02)00026-1 ↗
27. Vaisocherova H. · Anal. Chem. · 2008 · 80 · 789410.1021/ac8015888 ↗
28. Zhang Z. · Biomacromolecules · 2006 · 7 · 331110.1021/bm060750m ↗
29. Jiang S. · Adv. Mater. · 2010 · 22 · 92010.1002/adma.200901407 ↗
30. Carr L. R. · Biomaterials · 2011 · 32 · 689310.1016/j.biomaterials.2011.06.006 ↗
31. Cao Z. · Angew. Chem., Int. Ed. · 2010 · 49 · 377110.1002/anie.200907079 ↗
32. Abraham S. · Biomacromolecules · 2011 · 12 · 356710.1021/bm200778u ↗
33. Yang W. · Biomaterials · 2009 · 30 · 561710.1016/j.biomaterials.2009.06.036 ↗
34. Keefe A. J. · Nat. Chem. · 2012 · 4 · 6010.1038/nchem.1213 ↗
35. Veronese F. M. · Drug Discovery Today · 2005 · 10 · 145110.1016/S1359-6446(05)03575-0 ↗
36. Bailon P. · Bioconjugate Chem. · 2001 · 12 · 19510.1021/bc000082g ↗
37. Zhang L. · Clin. Pharmacol. Ther. · 2008 · 83 · 76110.1038/sj.clpt.6100400 ↗
38. Torchilin V. P. · Adv. Drug Delivery Rev. · 2002 · 54 · 23510.1016/S0169-409X(02)00019-4 ↗
39. Thurmond K. B. · J. Am. Chem. Soc. · 1997 · 119 · 665610.1021/ja9710520 ↗
40. Samarajeewa S. · J. Am. Chem. Soc. · 2012 · 134 · 123510.1021/ja2095602 ↗
41. Zhang S. Y. · J. Am. Chem. Soc. · 2011 · 133 · 1104610.1021/ja203133h ↗
42. Lin L. Y. · J. Controlled Release · 2011 · 152 · 3710.1016/j.jconrel.2011.01.009 ↗
43. Sun G. · Biomacromolecules · 2008 · 9 · 199710.1021/bm800246x ↗
44. Sun G. · Adv. Mater. · 2007 · 19 · 315710.1002/adma.200701973 ↗
45. Tian H. Y. · Prog. Polym. Sci. · 2012 · 37 · 23710.1016/j.progpolymsci.2011.06.004 ↗
46. Anderson J. M. · Adv. Drug Delivery Rev. · 1997 · 28 · 510.1016/S0169-409X(97)00048-3 ↗
47. Middleton J. C. · Biomaterials · 2000 · 21 · 233510.1016/S0142-9612(00)00101-0 ↗
48. Lohmeijer B. G. G. · Macromolecules · 2006 · 39 · 8583
49. Kiesewetter M .K. · Macromolecules · 2010 · 43 · 209310.1021/ma9025948 ↗
50. http://clinicaltrials.gov/ct2/results?term=dota.
51. Almutairi A. · Proc. Natl. Acad. Sci. U.S.A. · 2009 · 106 · 68510.1073/pnas.0811757106 ↗
52. Adam M. J. · Chem. Soc. Rev. · 2005 · 34 · 15310.1039/b313872k ↗
53. Makino K. · Chem. Pharm. Bull. · 1985 · 33 · 119510.1248/cpb.33.1195 ↗
54. Belbella A. · Int. J. Pharm. · 1996 · 129 · 9510.1016/0378-5173(95)04258-X ↗
55. Jung J. H. · Catal. Today · 2006 · 115 · 28310.1016/j.cattod.2006.02.060 ↗
56. Xu L. B. · Macromolecules · 2011 · 44 · 477710.1021/ma2000948 ↗
57. McCarthy D. W. · Nucl. Med. Biol. · 1997 · 24 · 3510.1016/S0969-8051(96)00157-6 ↗
58. Liu Y. J. · Mol. Pharmaceutics · 2009 · 6 · 189110.1021/mp900215p ↗